Thermo Fisher gets EU approval for $3.5B Phadia acquisition

08/29/2011 | MassDevice.com (Boston)

Thermo Fisher Scientific's purchase of Phadia, a maker of blood tests in Sweden, for $3.5 billion has received the green light from the European Commission. The transaction, which offers Thermo Fisher a broader footprint in specialty diagnostics, "would not raise competition concerns," the Commission said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park